Bruce J. Seeley

2017 - CTI BioPharma

In 2017, Bruce J. Seeley earned a total compensation of $1.5M as Executive Vice President, Chief Operating Officer at CTI BioPharma, a 190% increase compared to previous year.

Compensation breakdown

Bonus$125,439
Option Awards$938,978
Salary$384,827
Other$8,100
Total$1,457,344

Seeley received $939K in option awards, accounting for 64% of the total pay in 2017.

Seeley also received $125.4K in bonus, $384.8K in salary and $8.1K in other compensation.

Rankings

In 2017, Bruce J. Seeley's compensation ranked 7,141st out of 14,666 executives tracked by ExecPay. In other words, Seeley earned more than 51.3% of executives.

ClassificationRankingPercentile
All
7,141
out of 14,666
51st
Division
Manufacturing
2,654
out of 5,772
54th
Major group
Chemicals And Allied Products
867
out of 2,075
58th
Industry group
Drugs
676
out of 1,731
61st
Industry
Pharmaceutical Preparations
529
out of 1,333
60th
Source: SEC filing on March 30, 2018.

Seeley's colleagues

We found six more compensation records of executives who worked with Bruce J. Seeley at CTI BioPharma in 2017.

2017

Adam Craig

CTI BioPharma

Chief Executive Officer

2017

Jack Singer

CTI BioPharma

Chief Scientific Officer

2017

David Kirske

CTI BioPharma

Chief Financial Officer

2017

Louis Bianco

CTI BioPharma

Former Executive Vice President, Finance and Administration

2017

Matthew Plunkett

CTI BioPharma

Former Executive Vice President, Chief Business Officer

2017

Richard Love

CTI BioPharma

Chief Executive Officer

News

In-depth

You may also like